Patent ID: 11872309
Assignee: nan
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  Y | IPC A

Claim 0:
1. A method for treating at least one of a neurological disorder and a mental disorder in a subject, the method comprising administering to a subject suffering from the disorder, 0.1 to 25.0 mL of an oral liquid suspension comprising:
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamate (topiramate), present in 25±5 mg/mL;
water;
glycerin;
propylene glycol;
polyethylene glycol;
methylparaben;
sodium benzoate;
sorbitol;
saccharin;
sucralose;
xanthan gum;
carboxymethyl cellulose (CMC);
sodium phosphate; and
microcrystalline cellulose and colloidal silicon dioxide;
wherein the disorder comprises at least one of (a)-(c):
(a) epilepsy for a subject aged 2 years or older in adjunctive therapy for the treatment of:
partial-onset seizures,
primary generalized tonic-clonic seizures, or
generalized seizures of Lennox-Gastaut syndrome;

(b) epilepsy for a subject aged 16 years and older, undergoing conversion to monotherapy, with partial-onset seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single anti epileptic drug; or
(c) bipolar disorder for a subject, being treated for acute mood episodes with standard therapy, to delay the time to occurrence of mood episode.